鼓膜切开置管与药物灌注联合治疗难治性分泌性中耳炎的效果研究  

Effect of Tympanic Membrane Incision and Catheterization Combined with Drug Infusion in the Treatment of Refractory Secretory Otitis Media

作　　者：高文燕[1] GAO Wenyan(Department of Otolaryngology,Xintai People's Hospital,Tai'an,Shandong Province,271200 China)

机构地区：[1]新泰市人民医院耳鼻咽喉科,山东泰安271200

出　　处：《中外医疗》2023年第36期70-73,共4页China & Foreign Medical Treatment

摘　　要：目的 分析难治性分泌性中耳炎(secretory otitis media,SOM)患者采用鼓膜切开置管联合药物灌注治疗取得的效果。方法 方便选取2021年8月—2023年7月新泰市人民医院收治的98例难治性SOM患者为研究对象,使用随机数表法进行分为研究组和对照组,各49例。研究组采用鼓膜切开置管与药物灌注联合治疗,对照组仅采用鼓膜切开置管治疗。针对两组患者的疗效、语言频率听阈、静态声顺值、耳峰压值、咽鼓管功能障碍症状量表(Eustachian Tube Dysfunction Questionnaire,ETDQ-7)评分,以及并发症情况进行比较。结果研究组患者的治疗总有效率为95.92%,高于对照组的81.63%,差异有统计学意义(χ^(2)=5.018,P<0.05)。治疗后,研究组患者的静态声顺值、耳峰压值较对照组更高,语言频率听阈较对照组更低,差异有统计学意义(P均<0.05)。研究组患者治疗后的ETDQ-7评分为(8.65±2.02)分,较对照组的(11.56±1.98)分更低,差异有统计学意义(t=7.202,P<0.05)。两组并发症发生率对比,差异无统计学意义(P>0.05)。结论 难治性SOM患者采用鼓膜切开置管与药物灌注联合治疗效果可靠,能够提高听力水平,改善咽鼓管功能。Objective To analyze the effect of tympanic membrane incision and catheterization combined with drug infusion in refractory secretory otitis media(SOM).Methods 98 patients with refractory SOM admitted to Xintai People's Hospital from August 2021 to July 2023 were conveniently selected as the research subjects.They were divided into a study group and a control group using a random number table,with 49 patients in each group.The research group used a combination of tympanic membrane incision and catheterization combined with drug infusion for treatment,while the control group only used with tympanic membrane incision and catheterization for treatment.The efficacy,speech frequency hearing threshold,static sound compliance value,aural peak pressure value,Eustachian Tube Dysfunction Questionnaire(ETDQ-7) scores and complications were compared between the two groups.Results The total effective rate of treatment in the study group was 95.92%,which was higher than the control group's 81.63%,and the difference was statistically significant(χ^(2)=5.018,P<0.05).After treatment,the static acoustic compliance and ear peak pressure values of the study group patients were higher than those of the control group,and the hearing threshold of speech frequency was lower than that of the control group,and the difference was statistically significant(all P<0.05).The ETDQ-7 score of the study group patients after treatment was(8.65±2.02) points,which was lower than the control group's(11.56±1.98) points,and the difference was statistically significant(t=7.202,P<0.05).There was no statistically significant difference in the complication rate between the two groups(P>0.05).Conclusion The combined treatment of tympanic membrane incision and catheterization and drug infusion for refractory SOM patients is reliable,which can improve the hearing level and improve the eustachian tube function.

关 键 词：鼓膜切开置管 药物灌注 难治性分泌性中耳炎 

分 类 号：R4[医药卫生—临床医学]